Purple Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.72	7.4	14.49	15.03	10.89
Short-Term Investments	0.86	1.12	0.92	17.08	36.31
Cash & Short-Term Investments	9.57	8.52	15.41	32.11	47.2
Cash Growth	12.32%	-44.69%	-52.01%	-31.96%	-18.35%
Other Current Assets	0.29	0.38	0.38	1.14	1.27
Total Current Assets	9.87	8.91	15.79	33.26	48.47
Net Property, Plant & Equipment	0.35	0.29	0.47	0.68	0.9
Other Intangible Assets	7.36	27.84	28.04	20.68	20.48
Long-Term Investments	-	-	-	-	0.19
Other Long-Term Assets	-	-	-	-	0.16
Total Assets	17.57	37.04	44.3	54.62	70.2
Accounts Payable	2.07	1.46	3.53	2.13	1.47
Accrued Expenses	1.37	1.2	3.46	4.73	2.58
Current Portion of Leases	0.24	0.18	0.19	0.19	0.2
Other Current Liabilities	4.07	1.15	2.52	-	-
Total Current Liabilities	7.75	3.99	9.7	7.06	4.25
Long-Term Leases	-	-	0.16	0.32	0.55
Other Long-Term Liabilities	0.16	0.14	0.14	0.15	0.29
Total Long-Term Liabilities	0.16	0.14	0.3	0.47	0.84
Total Liabilities	7.91	4.13	10.01	7.52	5.09
Additional Paid-in Capital	180.79	177.55	171.64	164.49	160.73
Accumulated Other Comprehensive Income	-	-	0.02	-0.01	-
Retained Earnings	-171.08	-144.69	-137.45	-117.57	-95.91
Total Common Shareholders' Equity	9.71	32.86	34.21	46.91	64.83
Minority Interest	-0.06	0.05	0.09	0.19	0.28
Shareholders' Equity	9.66	32.91	34.3	47.1	65.11
Total Liabilities & Equity	17.57	37.04	44.3	54.62	70.2
Total Debt	0.24	0.18	0.35	0.52	0.75
Net Cash (Debt)	9.33	8.34	15.06	31.6	46.45
Net Cash Growth	11.86%	-44.62%	-52.34%	-31.98%	-18.38%
Net Cash Per Share	19.43	50.87	136.09	34.95	4.04
Book Value	9.71	32.86	34.21	46.91	64.83
Book Value Per Share	20.24	200.42	309.10	51.89	5.64
Tangible Book Value	2.35	5.02	6.16	26.23	44.35
Tangible Book Value Per Share	4.90	30.61	55.69	29.01	3.86

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q